BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents
- 1 October 2017
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 173, 139-147
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01-CA-044722-26)
This publication has 36 references indexed in Scilit:
- BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signalingeLife, 2013
- Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole DerivativesJournal of Medicinal Chemistry, 2013
- Clinical Experience Using Vitamin D and Analogs in the Treatment of Myelodysplasia and Acute Myeloid Leukemia: A Review of the LiteratureLeukemia Research and Treatment, 2012
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Cell Death & Differentiation, 2011
- BRAFMutations in Hairy-Cell LeukemiaNew England Journal of Medicine, 2011
- Silibinin can induce differentiation as well as enhance vitamin D3‐induced differentiation of human AML cells ex vivo and regulates the levels of differentiation‐related transcription factorsHematological Oncology, 2009
- Differential Regulation of Vitamin D Receptor (VDR) by the p53 FamilyJournal of Biological Chemistry, 2007
- The identification of potent and selective imidazole-based inhibitors of B-Raf kinaseBioorganic & Medicinal Chemistry Letters, 2006
- Mutations of the BRAF gene in human cancerNature, 2002
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999